Successful treatment of a chronic oroantral fistula infected with extensively drug resistant bacteria using long‐term oesophageal tube feeding and several non‐conventional treatments in a horse

2021 ◽  
Author(s):  
JR Fletcher ◽  
KY Yuen ◽  
AJ Stewart ◽  
AC Young ◽  
JS Gibson ◽  
...  
Keyword(s):  
Successful Treatment ◽  
Tube Feeding ◽  
Resistant Bacteria ◽  
Drug Resistant ◽  
Oroantral Fistula ◽  
Extensively Drug Resistant ◽  
Drug Resistant Bacteria

Extensively drug-resistant bacteria: Which ethical issues?

2017 ◽  
Vol 47 (5) ◽  
pp. 319-323 ◽  
Author(s):  
P. Vassal ◽  
P. Berthelot ◽  
J.P. Chaussinand ◽  
S. Jay ◽  
J.P. de Filippis ◽  
...  
Keyword(s):  
Ethical Issues ◽  
Resistant Bacteria ◽  
Drug Resistant ◽  
Extensively Drug Resistant ◽  
Drug Resistant Bacteria

scholarly journals Design, Engineering and Discovery of Novel α-Helical and β-Boomerang Antimicrobial Peptides against Drug Resistant Bacteria

2020 ◽  
Vol 21 (16) ◽  
pp. 5773 ◽  
Author(s):  
Surajit Bhattacharjya ◽  
Suzana K. Straus
Keyword(s):  
Antimicrobial Peptides ◽  
Resistant Bacteria ◽  
Drug Resistant ◽  
Antibiotic Development ◽  
Extensively Drug Resistant ◽  
Drug Resistant Bacteria ◽  
Drying Up ◽  
Further Development ◽  
Lps Binding

In an era where the pipeline of new antibiotic development is drying up, the continuous rise of multi-drug resistant (MDR) and extensively drug resistant (XDR) bacteria are genuine threats to human health. Although antimicrobial peptides (AMPs) may serve as promising leads against drug resistant bacteria, only a few AMPs are in advanced clinical trials. The limitations of AMPs, namely their low in vivo activity, toxicity, and poor bioavailability, need to be addressed. Here, we review engineering of frog derived short α-helical AMPs (aurein, temporins) and lipopolysaccharide (LPS) binding designed β-boomerang AMPs for further development. The discovery of novel cell selective AMPs from the human proprotein convertase furin is also discussed.

French recommendations for the prevention of ‘emerging extensively drug-resistant bacteria’ (eXDR) cross-transmission

2015 ◽  
Vol 90 (3) ◽  
pp. 186-195 ◽  
Author(s):  
D. Lepelletier ◽  
P. Berthelot ◽  
J.-C. Lucet ◽  
S. Fournier ◽  
V. Jarlier ◽  
...  
Keyword(s):  
Resistant Bacteria ◽  
Drug Resistant ◽  
Extensively Drug Resistant ◽  
Drug Resistant Bacteria ◽  
Cross Transmission

scholarly journals Emerging extensively drug-resistant bacteria (eXDR) in France in 2018

2020 ◽  
Vol 50 (8) ◽  
pp. 715-722
Author(s):  
M. Colomb-Cotinat ◽  
S. Soing-Altrach ◽  
A. Leon ◽  
Y. Savitch ◽  
I. Poujol ◽  
...  
Keyword(s):  
Resistant Bacteria ◽  
Drug Resistant ◽  
Extensively Drug Resistant ◽  
Drug Resistant Bacteria

Asymptomatic carriage of extensively drug-resistant bacteria (eXDR), a simple way to assess spontaneous clearance

2020 ◽  
Vol 104 (4) ◽  
pp. 503-507
Author(s):  
E. Farfour ◽  
A.-G. Si Larbi ◽  
J. Couturier ◽  
M. Lecuru ◽  
J.-W. Decousser ◽  
...  
Keyword(s):  
Resistant Bacteria ◽  
Spontaneous Clearance ◽  
Drug Resistant ◽  
Asymptomatic Carriage ◽  
Extensively Drug Resistant ◽  
Drug Resistant Bacteria
Sign in / Sign up

Export Citation Format

Share Document